March 23, 2015

The Ebola epidemic in West Africa deeply impacted public opinion at an international level. Doctors Without Borders/Médecins Sans Frontières (MSF) received massive financial support from thousands of donors all over the world. In 2014 alone, 70 million euros (approximately $93 million) were received through private donations, and 15 million (approximately $20 million) through public funds.

March 25, 2012

MSF calls on the stakeholders of the Global Fund to convene an emergency donor conference and to open a new early funding window to ensure that the Fund is fully functional in 2012.

February 08, 2012

Learn how a free trade agreement between the European Union and India could restrict access to affordable medicines for millions of people with HIV/AIDS and other diseases and conditions.

November 04, 2010

The crucial role India plays in supplying the developing world with affordable quality medicines is being threatened.

August 01, 2006

In the past 5 years, considerable progress has been made in scaling-up access to antiretroviral therapy.  Today, 1.3 million people are receiving treatment.  But a huge amount remains to be done.

February 01, 2006

Doctors Without Borders/Médecins Sans Frontières (MSF) is alarmed at the lack of availability of a key antiretroviral to treat HIV/AIDS, Gilead Science's tenofovir disoproxil fumarate (TDF), marketed as Viread®.